Chemical Structure : Alnuctamab
货号: PC-38851Not For Human Use, Lab Use Only.
Alnuctamab (CC-93269) is a T-cell redirecting bispecific antibody (BiTE) targeting BCMA for the treatment of multiple myeloma.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Alnuctamab (CC-93269) is a T-cell redirecting bispecific antibody (BiTE) targeting BCMA (TNFRSF17) and CD3ε for the treatment of multiple myeloma, binds bivalently to BCMA and monovalently to CD3ε in a 2+1 format.
Isotype: G1-kappa/lambda with domain crossover
Anti-[human TNFRSF17 (TNF receptor superfamily member 17, tumor necrosis factor receptor superfamily, member 17, B cell maturation antigen, BCMA, BCM, TNFRSF13A, CD269)] and anti-[human CD3E (CD3 epsilon, Leu-4)], monoclonal antibody, bispecific, trivalent.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Verkleij CPM, et al. Oncotarget. 2020 Nov 10;11(45):4076-4081.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright